Mondo Visione Worldwide Financial Markets Intelligence

FTSE Mondo Visione Exchanges Index:

CME Group Inc. Reports Third-Quarter 2012 Financial Results

Date 25/10/2012

CME Group Inc. (NASDAQ: CME) today reported revenues of $683 million and operating income of $396 million for the third quarter 2012. Net income attributable to CME Group was $218 million and diluted earnings per share were $0.66.

Third-quarter 2012 results included a non-recurring $16 million increase to the company's income tax provision related to increases in deferred income tax liabilities associated with S&P Dow Jones Indices and the company's acquisition of Pivot, Inc. On a non-GAAP basis, third-quarter diluted EPS would have been $0.70.1

"Given the dynamic and changing global environment, we continue to advocate on behalf of our customers, businesses and the futures industry as new regulations are being implemented," said CME Group Executive Chairman and President Terry Duffy. "At the same time, we remain focused on expanding our business to meet the needs of our global customers. We applied to the Financial Services Authority for approval to create a London-based exchange that will initially offer trading of foreign exchange futures products and ultimately expand into other products. We also announced an agreement to acquire the Kansas City Board of Trade, which gives us the opportunity to expand and diversify our wheat product portfolio and provide capital and operational efficiencies for our customers. Growth, efficiency and returning excess cash to shareholders continue to be our priorities."

"During the quarter, we continued to expand our industry-leading portfolio of diverse products as part of growing our global footprint," said CME Group Chief Executive Officer Phupinder Gill. "We strengthened our OTC product offering by announcing the launch of a deliverable interest rate swap futures product and portfolio margining of interest rate swaps and futures positions for customer accounts. With Dodd-Frank regulation driving changes in OTC energy markets, we also are working on providing flexible means of execution for participants in these markets. Overall, we are collaborating with buy-side and sell-side customers to provide the innovative products and services they need to manage their risk effectively in a continuously evolving marketplace."

Third-quarter 2012 average daily volume was 10.8 million contracts, down 26 percent from an exceptionally strong third-quarter 2011 which included the all-time record August 2011 average daily volume of 17.1 million contracts. This drove a 23 percent decrease in clearing and transaction fee revenues to $562 million. Third-quarter total average rate per contract was 82.2 cents, up 6 percent compared with third-quarter 2011.

Third-quarter 2012 operating expense was $287 million, below recent quarters and partially driven by the removal of expenses previously associated with the Dow Jones Indices business. This highlights the company's continued focus on managing the organization as efficiently as possible while still progressing with key longer-term growth initiatives. Third-quarter 2012 operating margin was 58 percent. Operating margin is defined as operating income as a percentage of total revenues.

During the third quarter, the effective tax rate was 40.7 percent[1], excluding the non-recurring item discussed earlier. As of September 30, the company had $2.1 billion of cash and marketable securities and $2.9 billion of debt.

CME Group will hold a conference call to discuss third-quarter 2012 results at 8:30 a.m. Eastern Time today. A live audio Webcast of the call will be available on the Investor Relations section of CME Group's Web site at www.cmegroup.com. An archived recording will be available for up to two months after the call.

 

1. A reconciliation of the non-GAAP financial results mentioned to the respective GAAP figures can be found within the Reconciliation of GAAP to Non-GAAP Measures chart at the end of the financial statements.

CME Group Inc. and Subsidiaries

Consolidated Balance Sheets

(in millions)








September 30, 2012


December 31, 2011

ASSETS





Current Assets:





Cash and cash equivalents


$

2,016.9



$

1,042.3


Marketable securities


62.0



47.6


Accounts receivable, net of allowance


296.9



289.4


Other current assets (includes $40.0 in restricted cash)


245.7



232.6


Cash performance bonds and guaranty fund contributions


7,395.3



9,333.9


Total current assets


10,016.8



10,945.8


Property, net of accumulated depreciation and amortization


705.4



821.9


Intangible assets—trading products


17,040.5



17,040.5


Intangible assets—other, net


2,879.5



3,312.8


Goodwill


7,538.3



7,984.0


Other assets (includes $20.5 in restricted cash)


1,677.5



653.7


Total Assets


$

39,858.0



$

40,758.7







LIABILITIES AND SHAREHOLDERS' EQUITY





Current Liabilities:





Accounts payable


$

44.5



$

31.1


Short-term debt


749.6




Other current liabilities


200.1



250.2


Cash performance bonds and guaranty fund contributions


7,395.3



9,333.9


Total current liabilities


8,389.5



9,615.2


Long-term debt


2,106.4



2,106.8


Deferred income tax liabilities, net


7,319.8



7,226.8


Other liabilities


254.1



187.6


Total Liabilities


18,069.8



19,136.4


Redeemable non-controlling interest


79.4



70.3


Shareholders' equity


21,708.8



21,552.0


Total Liabilities and Shareholders' Equity


$

39,858.0



$

40,758.7




















CME Group Inc. and Subsidiaries

Consolidated Statements of Income

(dollars in millions, except per share amounts; shares in thousands)








Quarter Ended


Nine Months Ended



September 30,


September 30,



2012


2011


2012


2011

Revenues









Clearing and transaction fees


$

562.2



$

732.7



1,826.9



$

2,111.8


Market data and information services


82.8



107.0



307.8



321.9


Access and communication fees


23.2



12.0



65.5



34.8


Other


15.0



22.5



53.5



75.6


Total Revenues


683.2



874.2



2,253.7



2,544.1


Expenses









Compensation and benefits


117.5



119.9



383.7



359.7


Communications


9.8



11.0



30.8



31.7


Technology support services


11.8



13.3



36.7



38.7


Professional fees and outside services


26.7



29.0



99.2



90.4


Amortization of purchased intangibles


26.2



33.0



90.3



99.2


Depreciation and amortization


34.5



32.4



103.0



95.1


Occupancy and building operations


18.8



18.5



57.8



56.9


Licensing and other fee agreements


19.2



22.6



63.2



64.7


Other


22.7



22.4



72.6



77.0


Total Expenses


287.2



302.1



937.3



913.4


Operating Income


396.0



572.1



1,316.4



1,630.7











Non-Operating Income (Expense)









Investment income


13.1



3.7



31.3



27.1


Gains (losses) on derivative investments








(0.1)


Interest and other borrowing costs


(30.2)



(29.0)



(88.2)



(87.8)


Equity in net gains (losses) of unconsolidated subsidiaries


16.5



(0.9)



14.8



(3.1)


Other non-operating income (expense)


0.4





65.6




Total Non-Operating


(0.2)



(26.2)



23.5



(63.9)


Income before Income Taxes


395.8



545.9



1,339.9



1,566.8


Income tax provision


176.9



230.9



601.3



499.1


Net Income


218.9



315.0



738.6



1,067.7


Less: net income (loss) attributable to redeemable non-controlling interest


0.9



(1.1)



9.1



1.3


Net Income Attributable to CME Group


$

218.0



$

316.1



$

729.5



$

1,066.4











Earnings per Common Share Attributable to CME Group:









Basic


$

0.66



$

0.95



$

2.20



$

3.20


Diluted


0.66



0.95



2.20



3.19


Weighted Average Number of Common Shares:









Basic


331,377



332,289



331,091



333,449


Diluted


332,458



333,337



332,147



334,507




























CME Group Inc. and Subsidiaries

Quarterly Operating Statistics












3Q 2011


4Q 2011


1Q 2012


2Q 2012


3Q 2012

Trading Days

64



63



62



64



63












Quarterly Average Daily Volume (ADV)











CME Group ADV (in thousands)











Product Line

3Q 2011


4Q 2011


1Q 2012


2Q 2012


3Q 2012

Interest rates

6,518



4,729



5,613



5,136



4,514


Equities

4,040



3,147



2,390



2,919



2,391


Foreign exchange

988



820



846



920



846


Energy

1,670



1,704



1,952



1,741



1,590


Agricultural commodities

1,032



1,004



1,122



1,288



1,171


Metals

454



315



385



372



327


Total

14,702



11,719



12,308



12,376



10,839












Venue










Electronic

12,463



9,864



10,177



10,595



9,293


Open outcry

1,557



1,173



1,348



1,109



979


Privately negotiated

257



204



229



238



208


Exchange-traded Total

14,276



11,240



11,754



11,942



10,481


CME ClearPort

426



479



554



434



358


Total

14,702



11,719



12,308



12,376



10,839






















Average Rate Per Contract (RPC)











CME Group RPC











Product Line

3Q 2011


4Q 2011


1Q 2012


2Q 2012


3Q 2012

Interest rates

$

0.479



$

0.480



$

0.475



$

0.485



$

0.481


Equities

0.703



0.705



0.692



0.674



0.685


Foreign exchange

0.801



0.828



0.841



0.807



0.808


Energy

1.580



1.507



1.517



1.496



1.473


Agricultural commodities

1.264



1.230



1.216



1.264



1.301


Metals

1.649



1.706



1.647



1.649



1.693


Average RPC

$

0.779



$

0.811



$

0.811



$

0.812



$

0.822












Venue










Exchange-traded

$

0.724



$

0.748



$

0.737



$

0.750



$

0.757


CME ClearPort

2.621



2.290



2.388



2.510



2.719
































CME Group Inc. and Subsidiaries

Reconciliation of GAAP to Non-GAAP Measures

(dollars in millions, except per share amounts; shares in thousands)







Quarter Ended




September 30, 2012


GAAP Results




Revenues


$

683.2



Expenses


287.2



Operating income


396.0







Operating margin


58.0%







Non-Operating income (expense)


(0.2)



Income before income taxes


395.8







Income tax provision (benefit)


176.9







Effective tax rate


44.7%







Net income


218.9



Less: Net income attributable to redeemable non-controlling interest


0.9



Net Income Attributable to CME Group


$

218.0







Earnings per Common Share Attributable to CME Group:




Basic


$

0.66



Diluted


0.66







Adjustments












Reduction to income tax provision1


(15.7)







Addition to net income


15.7











Non-GAAP results, excluding adjustments




Revenues


$

683.2



Expenses


287.2



Operating income


396.0







Operating margin


58.0%







Non-Operating income (expense)


(0.2)



Income before income taxes


395.8







Income tax provision (benefit)


161.2







Effective tax rate


40.7%







Net income


234.6



Less: Net income attributable to redeemable non-controlling interest


0.9



Net Income Attributable to CME Group


$

233.7







Adjusted earnings per Common Share Attributable to CME Group:




Basic


$

0.71



Diluted


0.70







Weighted Average Number of Common Shares:




Basic


331,377



Diluted


332,458







1) Adjustment to tax expense relates to increases in deferred income tax liabilities on S&P Dow Jones Indices due to tax filings as well as increases in deferred tax liabilities related to the acquisition of Pivot, Inc.